SUMOylation is a Therapeutic Vulnerability in High-risk Neuroblastoma

Therapeutic NAMPT inhibition reveals a targetable metabolic vulnerability in neuroblastoma.
Sophia Varriano, Amy Yu, Abantika Chakraborty +34
Journal of experimental & clinical cancer research : CR5 Aug 2026Peer-reviewedCC BYFull textNeurologyEurope PMCPMC
Circulating extracellular vesicles display immunotherapeutic targets and complement circulating tumor DNA in high-risk neuroblastoma
M. Auber, A. Nejaime, H.-D. Chang +13
bioRxiv21 Oct 2026PreprintAll rights reservedFull textOncologybioRxiv
Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma
Joshua Robert Goulding, Stijn Tim Couwenbergh, Sarah-Lee Bekaert +12
Cell Reports1 Oct 2026Peer-reviewedCC BY-NC-ND 4.0NeurologyCrossref
Heparan sulphate expression in high-risk neuroblastoma
Valeria Solari, Lucia Borriello, Jeremy E. Turnbull +1
Pediatric Surgery International3 Nov 2026Peer-reviewedCC BY 4.0Full textOncologyPMC
The role of personalised medicine in treating high-risk neuroblastoma in paediatric patients.
Daniele Ammeti, Debora Curci, Martina Franzin +3
Oncology reviews7 Oct 2026Peer-reviewedCC BYFull textNeurologyEurope PMC

Cite

BibTeX

@misc{kukkula2026sumoylation,
  title = {{SUMOylation is a Therapeutic Vulnerability in High-risk Neuroblastoma}},
  author = {A. Kukkula and S. Sriraman and V. Virtanen and S. L. Kuusela and L. K. Bubnic and I. Paatero and D. Bexell and M. Sundvall},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.05.749647},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.05.749647v1},
}

RIS

TY  - UNPB
TI  - SUMOylation is a Therapeutic Vulnerability in High-risk Neuroblastoma
AU  - A. Kukkula
AU  - S. Sriraman
AU  - V. Virtanen
AU  - S. L. Kuusela
AU  - L. K. Bubnic
AU  - I. Paatero
AU  - D. Bexell
AU  - M. Sundvall
PY  - 2026
DA  - 2026/09/05
PB  - bioRxiv
DO  - 10.64898/2026.09.05.749647
UR  - https://www.biorxiv.org/content/10.64898/2026.09.05.749647v1
ER  -

Related

Cite